341 results on '"Misumi, T."'
Search Results
2. Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
3. The emerging role of real-world data in oncology care in Japan
4. ARCAD-Asia initiative: leveraging yesterday’s data for tomorrow
5. Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study
6. A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)
7. EP08.03-03 S-1 and CDDP with Concurrent TRT Followed by Durvalumab in Elderly Population with Unresectable, LA-NSCLC in Japan: Post-hoc Analysis of SAMURAI
8. EP09.02-03 A Phase II Study on Aggressive Local Consolidative Therapy in Combination With Chemotherapy for Oligometastic NSCLC: TORG1529
9. MA18.08 A Phase 2 Study of Carboplatin, Etoposide and Nintedanib for Unresectable Small-Cell Lung Cancer with Idiopathic Pulmonary Fibrosis
10. Electromagnetic response and pseudo-zero-mode Landau levels of bilayer graphene in a magnetic field
11. Fluid flow and heat transfer of high-Rayleigh-number natural convection around heated spheres
12. 308P Phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)
13. 1015P Phase III study of ramucirumab plus docetaxel versus atezolizumab for PD-L1 negative or weakly positive advanced non-small cell lung cancer after disease progression on platinum-based therapy: WJOG10317L study (EMERALD)
14. EP08.01-005 A Multicenter Prospective Observational Study of Atezolizumab in Unresectable Advanced or Metastatic NSCLC in Japan: J-TAIL
15. 323P Five-year efficacy and safety in a randomized phase III trial investigating duration of adjuvant oxaliplatin-based therapy (3- vs. 6-months) for patients with high-risk stage II colon cancer: ACHIEVE-2 trial
16. 931MO Final overall survival analysis of phase III study of pemetrexed/cisplatin versus vinorelbine/cisplatin for completely resected non-squamous non-small cell lung cancer: The JIPANG Study
17. 1263P Biomarker analysis of plasma samples in YAMATO study: A randomized phase II trial comparing switching treatment of osimertinib following 8 months of afatinib (A) and osimertinib alone (B) in untreated advanced NSCLC patients with common EGFR mutation (TORG1939/WJOG12919L)
18. 726P Efficacy and safety of pembrolizumab plus olaparib combination therapy in recurrent cervical cancer progressed on platinum-based chemotherapy: Results from the phase II trial of GOTIC-025
19. 554P Novel clinical decision support (CDS) system optimizing adjuvant chemotherapy (ACT) for colorectal cancer (CRC) by integrating deep learning and circulating tumor DNA (ctDNA) molecular residual disease (MRD): GALAXY histotyping
20. 545P HIBRID: Histology and ct-DNA based risk-stratification with deep learning
21. P-61 Impacts of salvage chemotherapy after nivolumab therapy (NIVO): A REVIVE substudy
22. P-80 A multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab and FOLFOXIRI plus bevacizumab as the first-line treatment for metastatic colorectal cancer: A safety analysis of the QUATTRO-II study
23. D abstraction by H at a D-saturated Ru(0 0 1) surface
24. 1285P Final analysis of TORG1936/AMBITIOUS: Phase II study of atezolizumab for pretreated non-small cell lung cancer with idiopathic interstitial pneumonia
25. 543P A multicenter retrospective study to investigate risk factors for immune checkpoint inhibitor-induced pneumonitis in non-small cell lung cancer patients with comorbid interstitial pneumonia
26. Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
27. LBA70 OSIRAM-1: A multicenter, open label, randomized phase II study of osimertinib plus ramucirumab versus osimertinib alone as initial chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer (TORG1833)
28. LBA66 Afatinib versus chemotherapy for treatment-naïve non-small cell lung cancer with a sensitizing uncommon epidermal growth factor receptor mutation: A phase III study (ACHILLES/TORG1834)
29. 1294P A final analysis of a phase II study of durvalumab immediately after completion of chemoradiotherapy in unresectable stage III non–small-cell lung cancer: TORG1937 (DATE study)
30. P-149 QUATTRO-II: A multicenter randomized trial comparing CAPOXIRI + bevacizumab with FOLFOXIRI + bevacizumab as first-line treatment in patients with metastatic colorectal cancer: Efficacy and safety analysis
31. PO-1258: Intensity modulated radiation therapy for lymph node oligo-recurrence
32. Phase II study of atezolizumab for pretreated advanced / recurrent non-small cell lung cancer with idiopathic interstitial pneumonia (TORG1936 / AMBITIOUS study)
33. MA13.07 Phase I/II Study of Carboplatin Plus Weekly Nab-Paclitaxel in Aged ≥75 Patients with Squamous-Cell Lung Cancer: TORG1322
34. SAT-286 EFFECT OF DAPAGLIFLOZIN ON URINARY ALBUMIN EXCRETION AND HOME BLOOD PRESSURE PARAMETERS IN JAPANESE TYPE 2 DIABETES MELLITUS PATIENTS WITH ALBUMINURIA: Y-AIDA STUDY
35. Magnetoresistive measurement of switching behavior in nano-structured magnetic dot arrays
36. Sub-micron scale relief structures of GMR materials fabricated by half-milling control
37. Heat transfer and fluid flow of natural convection around large horizontal cylinders
38. D abstraction by H at a D-saturated Ru(001) surface
39. 535TiP - Phase II study of atezolizumab for pretreated advanced / recurrent non-small cell lung cancer with idiopathic interstitial pneumonia (TORG1936 / AMBITIOUS study)
40. MR Measurement of Sub-Micron Scale Relief Structures Fabricated in GMR Materials
41. Topologically twisted N = (2, 2) supersymmetric Yang-Mills theory on an arbitrary discretized Riemann surface
42. Effects of Trap Energy Levels on Reverse Recovery Surge of Silicon Power Diode
43. Highly efficient relief diffraction gratings inscribed in a chalcogenide bulk glass by a femtosecond laser
44. Characters of Lattice Fermions Based on the Hyperdiamond Lattice
45. Lattice Fermions Based on Higher-Dimensional Hyperdiamond Lattices
46. A study of correlation between CiOi defects and dynamic avalanche phenomenon of PiN diode using He ion irradiation
47. Electromagnetic response and pseudo-zero-mode Landau levels of bilayer graphene in a magnetic field
48. MP-04.10: DNA repair gene polymorphisms and toxicity in chemoradiotherapy for bladder cancer
49. MP-08.09: Docetaxel, etoposide, and estramustine phosphate in the treatment of hormone-refractory prostate cancer
50. Hypocapnic Alkalosis Enhances Oxidant-induced Apoptosis of Human Alveolar Epithelial Type II Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.